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therapy are relevant to the study but, unfortunately, were pub-
lished after the study period.
We hope that Dr Schouten and colleagues may be able to add
to our understanding by using the Revised Cardiac Risk Index and
the presence or absence of cardioprotective medication as criteria
in a similar study.
James May, MD, MS, FRACS, FACS
Ned Abraham, MB B, MM, FRACS, FACS
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Regarding “A prospective study of subclinical
myocardial damage in endovascular versus open repair
of infrarenal abdominal aortic aneurysms”
We read with interest the article by Abraham et al (J Vasc Surg
2005;41:377-81) reporting increased levels of cardiac troponin (cTn)
T in 9% of patients after elective endovascular repair and 25% of
patients after elective open repair of infrarenal abdominal aortic aneu-
rysm. These findings are similar to our own, in which increased levels
of cTnI were detected in 10 (29%) of 35 patients after elective open
aortic reconstruction.1 Because our study was performed in a unit that
did not perform endovascular abdominal aortic aneurysm repair at the
time, it seems unlikely that the authors’ suggestion that institutional
unfamiliarity with open aortic surgery, or more advanced arterial
disease in patients unsuitable for endovascular repair, can adequately
explain the higher incidence of myocardial injury in the open repair
group. One possible explanation for the findings may be related to the
fact that there was a higher incidence of previous myocardial infarction
in patients treated by endovascular repair (41%) compared with open
repair (22%). There is considerable evidence to support the use of
antiplatelet agents, -blockade, and statin therapy in reducing the
incidence of early and late myocardial infarction and cardiovascular
deaths in patients undergoing major vascular surgery.2-5 One would
expect a cardiologist to have been involved in the management of
myocardial infarction in these patients and, therefore, best medical
therapy to have been commenced. It is possible that such medical
optimization may have contributed to the reduction in myocardial
injury associated with endovascular repair. We would be most inter-
ested to know whether the authors have information on the relative
use of best medical therapy in their two groups of patients.
Donald J. Adam, MD, FRCSEd
Andrew W. Bradbury, BSc, MD, FRCSEd
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Reply
We thank the readers for their comments, and we were very
interested to see that they have obtained a similar incidence of cTnI
elevation in 29% of patients after elective open aortic reconstruc-
tion at a unit that did not perform endovascular abdominal aortic
aneurysm repair at the time. This, in our opinion, would confirm
our results that there is a statistically and almost certainly clinically
significant difference in the incidence of subclinical myocardial
damage after the two types of infrarenal abdominal aortic aneu-
rysm repair. In our two groups of patients, the preoperative man-
agement did not include routine -blockade and statin therapy.
Although this was not prospectively documented, medical optimi-
zation was more likely to have taken place in the open group in
view of the degree of severity of the planned procedure. It is quite
unlikely that medical optimization would have contributed to the
reduction in myocardial injury associated with endovascular repair.
Our study protocol, as approved by the local ethics commit-
tee, dictated analysis of all samples in batches in a way that was not
related to the day-to-day management of the individual patient.
This was to avoid unnecessary interventions based on the results of
a serum analysis that under normal circumstances would not take
place according to the best current practice of that time, because
troponin measurement is not a routine part of postoperative pa-
tient care.
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Regarding “Ultrasound findings after radiofrequency
ablation of the great saphenous vein: Descriptive
analysis”
In the recent article by Sergio Salles-Cunha et al,1 the authors
suggest a very high neovascularization rate after radiofrequency
ablation (RF) of the great saphenous vein (GSV), which does not
correspond to our own experience. The authors describe small
vessel networks (SVN), which covers without discrimination all
vessels smaller than 2 mm in the surrounding tissue of the treated
GSV, including muscular, collateral, and tributary veins and their
satellite arteries. The high prevalence of these SVN elements in the
groin area and at the thigh level is interpreted as the result of a
process similar to the neovascularization described after GSV liga-
tion and stripping. However, without a controlled assessment of
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the preoperative extent of the SVN, the possibility of pre-existing
SVN cannot be excluded, especially when the duplex ultrasound
method was not identical before and after surgery, with postoper-
ative setting optimization meant to maximize sensitivity.
In fact, many small vessels can be identified with ultrasonog-
raphy before any treatment, and there is no reason that RF ablates
them. For example, the external pudendal artery visible in contact
with the GSV termination in preoperative ultrasound examination
remains discernible after RF, in contact with the occluded GSV.
Similarly, it is common to visualize arterioles close to the GSV
during ultrasonography-guided sclerotherapy (Figure). Consider-
ing these arterioles as SVN, they cannot be attributed to neovas-
cularization. Regarding the veins, it is known that the saphe-
nofemoral junction (SFJ) tributaries, which are also covered by the
SVN definition, remain patent after RF in more than 90% of cases.1
Therefore, it is not surprising that the authors found a lower
prevalence of SVN when a high ligation was performed. It would
have been helpful for the authors to provide a more anatomically
precise SVN classification. It is difficult to assign an identical
pathologic effect to vessels so anatomically different as arterioles
and refluxing or not refluxing veins. In our experience, refluxing
veins observed after RF—excepting the cases of recanalization or
nonocclusion—involve only the low SFJ tributaries or the groin
ganglionic veins.
The persistence of a short patent segment at the termination of
the GSV is a known pattern, consistent with the endovenous
therapeutic concept that allows physiologic drainage of the SFJ
collaterals toward the deep system.2 However, the prognosis of
GSV termination recanalization in case of associated high ligation
should be more pejorative because of the possibility of physiologic
drainage of the recanalized GSV is suppressed. The rate of GSV
trunk recanalization in this study (35%) is much higher than
previously reported (9.5% at 2 years and 11.5% at 4 years).2,3
Knowing that only 20% of the GSVs with partial occlusion or
nonocclusion are refluxing, it is not obvious that the network
including the feeding vein, the recanalized GSV, and the draining
vein observed by the authors was inconsistent with a physiologic
circulation, especially in the absence of reflux.
Because the endovenous treatment concept is very different
from conventional surgery, it is mandatory to attentively assess the
results of RF. Ensuring an identical preoperative and postoperative
ultrasound method to establish consistent conclusions is also nec-
essary.
Olivier Pichot, MD
Denis Creton, MD
Chu de Grenoble
Grenoble, France
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We did not suggest a very high neovascularization rate after
radiofrequency ablation (RFA) of the great saphenous vein. We did
discuss a possible connection between what other authors called
neovascularization and what we prefer to name small vessel net-
works. A major reason why we selected small vessel network was to
avoid the connotation associated with the concept of neovascular-
ization. Our intention was also to critique the use of the term
neovascularization without proof that these vessels did not exist
before. For one reason, existing small vessels may dilate in response
to an inflammatory process and may constrict after the inflamma-
tion subsides. Clinically, thrombosis may occur in the postopera-
tive period in untreated segments proximal and distal to the
segment exposed to the RFA and also within the treated segment.
Furthermore, patients have complained of localized pain or dis-
comfort starting months after a successful RFA. This localized pain
was associated with a visible vein valve sinus either totally throm-
bosed or partially recanalized; pain was associated with a thrombus
that seemed hypoechoic enough to be considered recent. There is
growing evidence associating the appearance of small vessels, in-
cluding arterialized flow, with thrombus.
In our articles, we also made the distinction between recana-
lization and reflux. The term recanalization was preferred to avoid
the clinical inference associated with the concept of reflux. At early
stages of recanalization, clinical reflux is commonly absent. This
recanalization can be temporary and limited in length. (A reason
why recanalization was higher in this series than previously re-
ported may be that we considered recanalization segments as short
as 1 or 2 cm occurring at any level.) An unstable cycle of throm-
bosis, inflammation, thrombolysis, recanalization, reduction of
inflammation, low-flow condition, and then new thrombosis has
been suspected. Eventually the recanalization either becomes wide
enough to be part of a local network of small vessels or thrombosis
dominates, and, with thrombus aging, the vein segment becomes
atretic and atrophic and eventually disappears as such, becoming
unrecognizable by ultrasonography.
We also have described small vessel networks associated with
telangiectasias. It is not surprising to detect small vessel networks
in these patients before or after treatment of the saphenous vein.
Figure. Pretreatment duplex image showing collateral veins and
arteries close to the refluxing great saphenous vein (GSV) trunk.
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